CUSIP: 42225T107
Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
73,581,273
-
Total 13F shares
-
55,255,923
-
Share change
-
-2,406,756
-
Total reported value
-
$132,053,590
-
Put/Call ratio
-
675%
-
Price per share
-
$2.39
-
Number of holders
-
135
-
Value change
-
-$6,513,943
-
Number of buys
-
56
-
Number of sells
-
74
Quarterly Holders Quick Answers
What is CUSIP 42225T107?
CUSIP 42225T107 identifies HCAT - Health Catalyst, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Previous quarter:
Q3 2025
Recent filing periods for CUSIP 42225T107:
Institutional Holders of Health Catalyst, Inc. - Common Stock, $0.01 par value (HCAT) as of Q4 2025
As of 31 Dec 2025,
Health Catalyst, Inc. - Common Stock, $0.01 par value (HCAT) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,255,923 shares.
The largest 10 holders included
First Light Asset Management, LLC, BlackRock, Inc., VANGUARD GROUP INC, CDC Financial, Inc., Whetstone Capital Advisors, LLC, Impax Asset Management Group plc, Nepsis Inc., GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, and STATE STREET CORP.
This page lists
135
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.